PHASQ Insider Trading - PhaseBio Pharmaceuticals, Inc.

Ações de Insider

12,488,536 shares

Pontuação de Sentimento de Insider

A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.

É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com a maior acumulação de insiders.

Veja as Ações de Maior Classificação

Pontuação de Sentimento dos Oficiais

A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.

Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.

Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com maior sentimento dos insiders.

Veja as Ações de Maior Classificação

Principais Métricas de Insider

Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.

Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).

Número Líquido de Insiders Comprando (Classificação)

N/A

Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).

Percentual do Float Comprado por Insiders (Classificação)

N/A

Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.

Gráfico de Negociação de Insider

PhaseBio Pharmaceuticals, Inc. negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.

Roster de Insider e Métricas de Lucratividade

Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.

See our leaderboard of most profitable insider traders.

Insider	Lucro Médio (%)	Ações Possuídas	Ajuste de Divisão

Report errors via our new Insider Auditing Tool

Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em PHASQ / PhaseBio Pharmaceuticals, Inc.. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação	Insider	Reported Shares	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custo	Dias até Máx	Preço em Máx	Lucro Máximo ($)	Retorno Máximo (%)
2021-08-18	Thorp Clay	10,000	3.0000	10,000	3.0000	30,000	76	4.05	10,500	35.00
2021-08-18	Hutson Nancy J	3,000	3.0800	3,000	3.0800	9,240
2020-12-03	HARRIGAN EDMUND	6,000	4.1200	6,000	4.1200	24,720
2020-11-24	Thorp Clay	2,000	3.5000	2,000	3.5000	7,000
2020-11-23	Thorp Clay	3,000	3.6700	3,000	3.6700	11,010
2018-12-17	Hutson Nancy J	1,000	4.4600	1,000	4.4600	4,460
2018-12-13	Ballance David James	1,000	3.9400	1,000	3.9400	3,940
2018-12-13	Mow Jonathan P	1,000	3.6900	1,000	3.6900	3,690
2018-12-11	York Michael	1,500	3.8800	1,500	3.8800	5,820

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades

Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo

Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em PHASQ / PhaseBio Pharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação	Insider	Reported Shares	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custo	Dias até Mín	Preço em Mín	Máxima Perda Evitada ($)	Máxima Perda Evitada (%)
2022-10-25	NEW ENTERPRISE ASSOCIATES 13 LP	1,784,109	0.1470	1,784,109	0.1470	262,264	8	0.0701	-137,198	-52.31
2021-05-20	Burkhardt Glen	3,811	3.2900	3,811	3.2900	12,538
2020-11-23	Burkhardt Glen	3,497	3.4500	3,497	3.4500	12,065

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

Histórico de Transações

Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.

Arquivo Data	Data da Operação	Formulário	Insider	Ticker	Título de Segurança	Código	Direto	Preço de Exercício Preço Unitário	Preço por Unidade	Unidades Alteradas	Valor Alterado (1K)	Opções Restantes	Ações Restantes
2023-05-19	2023-05-19	4	Humphries William D.	PHAS	Common Stock	M - Exercise	D			2,538			2,538
2023-05-19	2023-05-19	4	Thorp Clay	PHAS	Common Stock	M - Exercise	D			3,750			36,693
2023-05-19	2023-05-19	4	van den Broek Richard	PHAS	Common Stock	A - Award	D			3,750			0
2023-05-19	2023-05-19	4	Loewy Caroline M	PHAS	Common Stock	M - Exercise	D			3,750			3,750
2023-05-19	2023-05-19	4	Sapir Alex	PHAS	Common Stock	M - Exercise	D			3,750			3,750
2023-05-19	2023-05-19	4	HARRIGAN EDMUND	PHAS	Common Stock	M - Exercise	D			3,750			9,750
2023-05-19	2023-05-19	4	Hutson Nancy J	PHAS	Common Stock	M - Exercise	D			3,750			37,510
2022-10-26	2022-10-25	4	NEW ENTERPRISE ASSOCIATES 13 LP	PHAS	Common Stock	S - Sale	D		0.1470	-1,784,109	-262		4,857,525
2022-05-24	2022-05-20	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		0.6813	10,917	7		41,236
2022-05-24	2022-05-20	4	Mow Jonathan P	PHAS	Common Stock	A - Award	D		0.6813	10,918	7		132,502
2022-05-24	2022-05-20	4	Hanson Kristopher	PHAS	Common Stock	A - Award	D		0.6813	4,831	3		8,463
2022-05-24	2022-05-20	4	Birchall Jonathan	PHAS	Common Stock	A - Award	D		0.6813	20,000	14		20,000
2022-05-24	2022-05-23	4	Burkhardt Glen	PHAS	Common Stock	S - Sale	D		0.7900	-11,248	-9		0
2022-05-24	2022-05-20	4	Burkhardt Glen	PHAS	Common Stock	A - Award	D		0.6813	11,248	8		11,248
2022-05-24	2022-05-20	4	Sharp John P	PHAS	Common Stock	A - Award	D		0.6813	6,026	4		65,767
2022-05-20	2021-08-18	4/A	Hutson Nancy J Held in an individual retirement account for the benefit of the Reporting Person	PHAS	Common Stock	P - Purchase	I		3.0800	3,000	9		4,000
2022-05-20	2022-05-19	4	Thorp Clay	PHAS	Restricted Stock Units	A - Award	D			3,750		3,750
2022-05-20	2022-05-19	4	Thorp Clay	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0.84		17,500		17,500
2022-05-20	2022-05-19	4	Humphries William D.	PHAS	Restricted Stock Units	A - Award	D			3,750		3,750
2022-05-20	2022-05-19	4	Humphries William D.	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0.84		17,500		17,500
2022-05-20	2022-05-19	4	Loewy Caroline M	PHAS	Restricted Stock Units	A - Award	D			3,750		3,750
2022-05-20	2022-05-19	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0.84		17,500		17,500
2022-05-20	2022-05-19	4	Sapir Alex	PHAS	Restricted Stock Units	A - Award	D			3,750		3,750
2022-05-20	2022-05-19	4	Sapir Alex	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0.84		17,500		17,500
2022-05-20	2022-05-19	4	Hutson Nancy J	PHAS	Restricted Stock Units	A - Award	D			3,750		3,750
2022-05-20	2022-05-19	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0.84		17,500		17,500
2022-05-20	2022-05-19	4	van den Broek Richard	PHAS	Restricted Stock Units	A - Award	D			3,750		3,750
2022-05-20	2022-05-19	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0.84		17,500		17,500
2022-05-20	2022-05-19	4	HARRIGAN EDMUND	PHAS	Restricted Stock Units	A - Award	D			3,750		3,750
2022-05-20	2022-05-19	4	HARRIGAN EDMUND	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0.84		17,500		17,500
2022-02-28	2022-02-24	4	Burkhardt Glen	PHAS	Employee Stock Option (right to buy)	A - Award	D	1.13		87,500		87,500
2022-02-28	2022-02-24	4	Burkhardt Glen	PHAS	Restricted Stock Unit	A - Award	D			18,750		18,750
2022-02-28	2022-02-24	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	A - Award	D	1.13		115,500		115,500
2022-02-28	2022-02-24	4	Sharp John P	PHAS	Restricted Stock Unit	A - Award	D			24,750		24,750
2022-02-28	2022-02-24	4	Birchall Jonathan	PHAS	Employee Stock Option (right to buy)	A - Award	D	1.13		52,500		52,500
2022-02-28	2022-02-24	4	Birchall Jonathan	PHAS	Restricted Stock Unit	A - Award	D			11,250		11,250
2022-02-28	2022-02-24	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	A - Award	D	1.13		87,500		87,500
2022-02-28	2022-02-24	4	Arnold Susan Elizabeth	PHAS	Restricted Stock Unit	A - Award	D			18,750		18,750
2022-02-28	2022-02-24	4	Lee John Sang	PHAS	Employee Stock Option (right to buy)	A - Award	D	1.13		115,500		115,500
2022-02-28	2022-02-24	4	Lee John Sang	PHAS	Restricted Stock Unit	A - Award	D			24,750		24,750
2022-02-28	2022-02-24	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	1.13		385,000		385,000
2022-02-28	2022-02-24	4	Mow Jonathan P	PHAS	Restricted Stock Unit	A - Award	D			82,500		82,500
2022-02-28	2022-02-24	4	Hanson Kristopher	PHAS	Employee Stock Option (right to buy)	A - Award	D	1.13		87,500		87,500
2022-02-28	2022-02-24	4	Hanson Kristopher	PHAS	Restricted Stock Unit	A - Award	D			18,750		18,750
2021-11-23	2021-11-19	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		2.0100	2,559	5		30,319
2021-11-23	2021-11-19	4	Mow Jonathan P	PHAS	Common Stock	A - Award	D		2.0100	5,623	11		172,473
2021-11-23	2021-11-19	4	Sharp John P	PHAS	Common Stock	A - Award	D		2.0100	2,017	4		59,741
2021-11-23	2021-11-19	4	Hanson Kristopher	PHAS	Common Stock	A - Award	D		2.0100	1,545	3		3,632
2021-11-23	2021-11-19	4	Burkhardt Glen	PHAS	Common Stock	S - Sale	D		2.3700	-5,766	-14		0
2021-11-23	2021-11-19	4	Burkhardt Glen	PHAS	Common Stock	A - Award	D		2.0100	5,766	12		5,766
2021-11-09	2021-11-08	4	Birchall Jonathan	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.37	3.3700	250,000	842	250,000
2021-11-08	2021-11-08	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	M - Exercise	D	3.15	3.1500	-7,400	-23	0
2021-11-08	2021-11-08	4	Hutson Nancy J	PHAS	Common Stock	M - Exercise	D		3.1500	7,400	23		33,760
2021-11-08	2021-11-05	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	M - Exercise	D	3.15	3.1500	-1,500	-5	7,400
2021-11-08	2021-11-05	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	M - Exercise	D	2.26	2.2600	-24,860	-56	2,256
2021-11-08	2021-11-05	4	Hutson Nancy J	PHAS	Common Stock	M - Exercise	D		3.1500	1,500	5		26,360
2021-11-08	2021-11-05	4	Hutson Nancy J	PHAS	Common Stock	M - Exercise	D		2.2600	24,860	56		24,860
2021-11-03	2021-11-03	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.68	1.6800	-7,500	-13	90,582
2021-11-03	2021-11-03	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1.6800	7,500	13		57,724
2021-11-03	2021-11-03	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.24	1.2400	-20,000	-25	108,767
2021-11-03	2021-11-03	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1.2400	20,000	25		166,850
2021-09-15	2021-09-14	4	Humphries William D.	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	2.80		28,000		28,000
2021-09-03	2021-07-12	4/A	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.74		-4,519		0
2021-09-03	2021-07-12	4/A	Arnold Susan Elizabeth	PHAS	Common Stock	M - Exercise	D		1.7400	4,519	8		27,760
2021-09-03	2021-08-03	4/A	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.68		-7,500		98,082
2021-09-03	2021-08-03	4/A	Sharp John P	PHAS	Common Stock	M - Exercise	D		1.6800	7,500	13		50,224
2021-08-30	2021-08-27	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.24		-20,000		128,767
2021-08-30	2021-08-27	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1.2400	20,000	25		146,850
2021-08-19	2021-08-18	4	Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person	PHAS	Common Stock	P - Purchase	I		3.0800	3,000	9		4,000
2021-08-18	2021-08-18	4	Thorp Clay	PHAS	Common Stock	P - Purchase	D		3.0000	10,000	30		32,943
2021-08-04	2021-08-03	4	Sharp John P	PHAS	Common Stock	A - Award	D		1.6800	7,500	13		50,224
2021-07-14	2021-07-12	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		1.7400	4,519	8		27,760
2021-06-04	2021-06-03	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.53		14,000		14,000
2021-06-04	2021-06-03	4	Sapir Alex	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.53		14,000		14,000
2021-06-04	2021-06-03	4	HARRIGAN EDMUND	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.53		14,000		14,000
2021-06-04	2021-06-03	4	Klein Peter Justin	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.53		14,000		14,000
2021-06-04	2021-06-03	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.53		14,000		14,000
2021-06-04	2021-06-03	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.53		14,000		14,000
2021-06-04	2021-06-03	4	Thorp Clay	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.53		14,000		14,000
2021-05-24	2021-05-20	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		2.8000	5,257	15		23,241
2021-05-24	2021-05-20	4	York Michael	PHAS	Common Stock	A - Award	D		2.8000	2,897	8		7,059
2021-05-24	2021-05-20	4	Hanson Kristopher	PHAS	Common Stock	A - Award	D		2.8000	1,088	3		2,087
2021-05-24	2021-05-20	4	Mow Jonathan P	PHAS	Common Stock	A - Award	D		2.8000	3,964	11		126,850
2021-05-24	2021-05-20	4	Burkhardt Glen	PHAS	Common Stock	S - Sale	D		3.2900	-3,811	-13		0
2021-05-24	2021-05-20	4	Burkhardt Glen	PHAS	Common Stock	A - Award	D		2.8000	3,811	11		3,811
2021-05-24	2021-05-20	4	Sharp John P	PHAS	Common Stock	A - Award	D		2.8000	1,419	4		42,724
2021-02-09	2021-02-05	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	4.31		234,000		234,000
2021-02-09	2021-02-05	4	Hanson Kristopher	PHAS	Employee Stock Option (right to buy)	A - Award	D	4.31		36,000		36,000
2021-02-09	2021-02-05	4	York Michael	PHAS	Employee Stock Option (right to buy)	A - Award	D	4.31		36,000		36,000
2021-02-09	2021-02-05	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	A - Award	D	4.31		36,000		36,000
2021-02-09	2021-02-05	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	A - Award	D	4.31		76,500		76,500
2021-02-09	2021-02-05	4	Lee John Sang	PHAS	Employee Stock Option (right to buy)	A - Award	D	4.31		76,500		76,500
2021-02-09	2021-02-05	4	Burkhardt Glen	PHAS	Employee Stock Option (right to buy)	A - Award	D	4.31		36,000		36,000
2020-12-04	2020-12-03	4	HARRIGAN EDMUND	PHAS	Common Stock	P - Purchase	D		4.1200	6,000	25		6,000
2020-11-24	2020-11-24	4	Thorp Clay	PHAS	Common Stock	P - Purchase	D		3.5000	2,000	7		22,943
2020-11-24	2020-11-23	4	Thorp Clay	PHAS	Common Stock	P - Purchase	D		3.6700	3,000	11		20,943
2020-11-23	2020-11-20	4	Sharp John P	PHAS	Common Stock	A - Award	D		3.0000	1,305	4		41,305
2020-11-23	2020-11-20	4	Hanson Kristopher	PHAS	Common Stock	A - Award	D		3.0000	999	3		999
2020-11-23	2020-11-20	4	York Michael	PHAS	Common Stock	A - Award	D		3.0000	2,662	8		4,162
2020-11-23	2020-11-20	4	Ballance David James	PHAS	Common Stock	A - Award	D		3.0000	919	3		8,519
2020-11-23	2020-11-20	4	Mow Jonathan P	PHAS	Common Stock	A - Award	D		3.0000	3,643	11		122,886
2020-11-23	2020-11-20	4	Arnold Susan Elizabeth	PHAS	Common Stock	A - Award	D		3.0000	4,832	14		17,984
2020-11-23	2020-11-23	4	Burkhardt Glen	PHAS	Common Stock	S - Sale	D		3.4500	-3,497	-12		0
2020-11-23	2020-11-20	4	Burkhardt Glen	PHAS	Common Stock	A - Award	D		3.0000	3,497	10		3,497
2020-11-18	2020-11-16	4	Thorp Clay By Catalysta Ventures, LLC	PHAS	Common Stock	J - Other	I			10,586			15,432
2020-11-18	2020-11-16	4	Thorp Clay	PHAS	Common Stock	J - Other	D			2,144			17,943
2020-11-18	2020-11-16	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Common Stock	J - Other	I			-52,397			0
2020-10-05	2020-10-01	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.15	1.1500	-5,423	-6	0
2020-10-05	2020-10-01	4	Arnold Susan Elizabeth	PHAS	Common Stock	M - Exercise	D		1.1500	5,423	6		13,152
2020-10-05	2020-02-27	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.15	1.1500	-5,423	-6	0
2020-10-05	2020-02-27	4	Arnold Susan Elizabeth	PHAS	Common Stock	M - Exercise	D		1.1500	5,423	6		7,729
2020-08-24	2020-08-21	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.24		-10,000		148,767
2020-08-24	2020-08-21	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1.2400	10,000	12		119,243
2020-08-17	2020-08-14	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.69		-5,000		105,582
2020-08-17	2020-08-14	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1.6900	5,000	8		40,000
2020-06-05	2020-06-03	4	Sapir Alex	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4.86		4,909		4,909
2020-06-05	2020-06-03	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	0.00		16,000		16,000
2020-06-05	2020-06-03	4	HARRIGAN EDMUND	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4.86		16,000		16,000
2020-06-05	2020-06-03	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4.86		16,000		16,000
2020-06-05	2020-06-03	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4.86		16,000		16,000
2020-06-05	2020-06-03	4	Klein Peter Justin	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4.86		16,000		16,000
2020-06-05	2020-06-03	4	Thorp Clay	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	4.86		16,000		16,000
2020-02-14	2020-02-12	4	Burkhardt Glen	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		20,000		20,000
2020-02-14	2020-02-12	4	Burkhardt Glen	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		55,000		55,000
2020-02-14	2020-02-12	4	York Michael	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		55,000		55,000
2020-02-14	2020-02-12	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		100,000		100,000
2020-02-14	2020-02-12	4	Hanson Kristopher	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		55,000		55,000
2020-02-14	2020-02-12	4	Sapir Alex	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		32,000		32,000
2020-02-14	2020-02-12	4	Lee John Sang	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		100,000		100,000
2020-02-14	2020-02-12	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		55,000		55,000
2020-02-14	2020-02-12	4	Ballance David James	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		55,000		55,000
2020-02-14	2020-02-12	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.19		290,000		290,000
2019-10-07	2019-10-07	4	Hanson Kristopher	PHAS	Employee Stock Option (right to buy)	A - Award	D	4.17		66,000		66,000
2019-09-10	2019-09-06	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.24		-19,000		158,767
2019-09-10	2019-09-06	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1.2400	19,000	24		109,243
2019-08-22	2019-08-21	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.44		-5,000		4,038
2019-08-22	2019-08-21	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.69		-10,000		110,582
2019-08-22	2019-08-21	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1.4400	5,000	7		35,000
2019-08-22	2019-08-21	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1.6900	10,000	17		30,000
2019-07-03	2019-07-01	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Common Stock	S - Sale	I		14.0000	-459	-6		415,959
2019-07-03	2019-07-01	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Common Stock	S - Sale	I		14.0000	-255	-4		52,397
2019-07-03	2019-07-01	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	S - Sale	I		14.0000	-180	-3		162,890
2019-07-03	2019-07-01	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Common Stock	S - Sale	I		14.0000	-2,014	-28		1,818,638
2019-06-20	2019-06-18	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Common Stock	S - Sale	I		14.0000	-63	-1		416,418
2019-06-20	2019-06-18	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Common Stock	S - Sale	I		14.0000	-35	-0		52,655
2019-06-20	2019-06-18	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	S - Sale	I		14.0000	-25	-0		163,074
2019-06-20	2019-06-18	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Common Stock	S - Sale	I		14.0000	-277	-4		1,820,656
2019-05-24	2019-05-22	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	M - Exercise	D	1.69		-15,000		120,582
2019-05-24	2019-05-22	4	Sharp John P	PHAS	Common Stock	M - Exercise	D		1.6900	15,000	25		20,000
2019-05-21	2019-05-20	4	Mow Jonathan P	PHAS	Employee stock option (right to buy)	M - Exercise	D	1.24		-19,131		0
2019-05-21	2019-05-20	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		1.2400	19,131	24		90,243
2019-05-21	2019-05-17	4	Mow Jonathan P	PHAS	Employee stock option (right to buy)	M - Exercise	D	2.27		-19,913		0
2019-05-21	2019-05-17	4	Mow Jonathan P	PHAS	Common Stock	M - Exercise	D		2.2700	19,913	45		71,112
2019-05-13	2019-05-09	4	Thorp Clay	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13.23		11,000		11,000
2019-05-13	2019-05-09	4	Hutson Nancy J	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13.23		11,000		11,000
2019-05-13	2019-05-09	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13.23		9,167		9,167
2019-05-13	2019-05-09	4	HARRIGAN EDMUND	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13.23		4,583		4,583
2019-05-13	2019-05-09	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13.23		2,750		2,750
2019-05-13	2019-05-09	4	Klein Peter Justin	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13.23		11,000		11,000
2019-05-13	2019-05-09	4	Mukhopadhyay Bibhash	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	13.23		11,000		11,000
2019-03-01	2019-02-27	4	TUFTS LINDA	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.15		36,000		36,000
2019-03-01	2019-02-27	4	Ballance David James	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.15		45,000		45,000
2019-03-01	2019-02-27	4	Hutson Nancy J	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.15		8,900		8,900
2019-03-01	2019-02-27	4	Klein Peter Justin	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.15		36,000		36,000
2019-03-01	2019-02-27	4	Lee John Sang	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.15		100,000		100,000
2019-03-01	2019-02-27	4	Loewy Caroline M	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.15		8,900		8,900
2019-03-01	2019-02-27	4	Sharp John P	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.15		100,000		100,000
2019-03-01	2019-02-27	4	Thorp Clay	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.15		36,000		36,000
2019-03-01	2019-02-27	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.15		23,000		23,000
2019-03-01	2019-02-27	4	van den Broek Richard	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.15		22,000		22,000
2019-03-01	2019-02-27	4	York Michael	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.15		45,000		45,000
2019-03-01	2019-02-27	4	Mukhopadhyay Bibhash	PHAS	Non-employee Director Stock Option (right to buy)	A - Award	D	3.15		36,000		36,000
2019-03-01	2019-02-27	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.15		263,000		263,000
2019-03-01	2019-02-27	4	Arnold Susan Elizabeth	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.15		45,000		45,000
2018-12-17		3/A	Ballance David James	PHAS	Common Stock		D						6,600
2018-12-17	2018-12-17	4	Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person	PHAS	Common Stock	P - Purchase	I		4.4600	1,000	4		1,000
2018-12-17	2018-12-13	4	Ballance David James	PHAS	Common Stock	P - Purchase	D		3.9400	1,000	4		7,600
2018-12-17	2018-12-13	4	HARRIGAN EDMUND	PHAS	Employee Stock Option (right to buy)	A - Award	D	3.65		68,966		68,966
2018-12-17	2018-12-13	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3.6900	1,000	4		51,199
2018-12-13	2018-12-10	4/A	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3.8500	800	3		50,199
2018-12-13	2018-12-07	4/A	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3.8900	700	3		49,399
2018-12-11	2018-12-10	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3.8500	800	3		51,699
2018-12-11	2018-12-07	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	P - Purchase	I		3.8800	2,200	9		50,899
2018-12-11	2018-12-07	4	Sharp John P	PHAS	Common Stock	P - Purchase	D		3.8400	5,000	19		5,000
2018-12-11	2018-12-11	4	York Michael	PHAS	Common Stock	P - Purchase	D		3.8800	1,500	6		1,500
2018-12-06	2018-12-04	4	Thorp Clay	PHAS	Common Stock	P - Purchase	D		3.1300	4,000	13		15,799
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series D Preferred Stock	C - Conversion	I			-1,124,301		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-437,706		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-4,349	-22	437,706
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series C-1 Preferred Stock	X - Other	I		0.1200	181,190	22	442,055
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0.12		-181,190		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series B Preferred Stock	C - Conversion	I			-3,279,627		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series B Preferred Stock	S - Sale	I		5.0000	-1,177	-6	3,279,627
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Series B Preferred Stock	X - Other	I		0.1200	49,030	6	3,280,804
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Warrants to Purchase Series B Preferred Stock	X - Other	I	0.12		-49,030		0
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Common Stock	P - Purchase	I		5.0000	1,800,000	9,000		6,641,634
2018-10-24	2018-10-22	4	NEW ENTERPRISE ASSOCIATES 13 LP See Note 2	PHAS	Common Stock	C - Conversion	I			4,841,634			4,841,634
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Series B Preferred Stock	C - Conversion	D			-2,303		0
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Series B Preferred Stock	S - Sale	D		5.0000	-3	-0	2,303
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Series B Preferred Stock	X - Other	D		0.1200	103	0	2,306
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Warrants to Purchase Series B Preferred Stock	X - Other	D	0.12		-103		0
2018-10-24	2018-10-22	4	Klein Peter Justin	PHAS	Common Stock	C - Conversion	D			2,303			2,303
2018-10-24	2018-10-22	4	Arnold Susan Elizabeth	PHAS	Series B Preferred Stock	C - Conversion	D			-2,306		0
2018-10-24	2018-10-22	4	Arnold Susan Elizabeth	PHAS	Series B Preferred Stock	M - Exercise	D		0.1200	103	0	2,306
2018-10-24	2018-10-22	4	Arnold Susan Elizabeth	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	D	0.12		-103		0
2018-10-24	2018-10-22	4	Arnold Susan Elizabeth	PHAS	Common Stock	C - Conversion	D			2,306			2,306
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Series D Preferred Stock	C - Conversion	I			-740,337		0
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-1,664,217		0
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-2,734	-14	1,664,217
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Series C-1 Preferred Stock	X - Other	I		0.1200	113,891	14	1,666,951
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0.12		-113,891		0
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Common Stock	P - Purchase	I		5.0000	600,000	3,000		3,004,554
2018-10-24	2018-10-22	4	ASTRAZENECA PLC By Zeneca, Inc.	PHAS	Common Stock	C - Conversion	I			2,404,554			2,404,554
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Series D Preferred Stock	C - Conversion	I			-226,061		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-24,709		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-272,107		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-40,420		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-13,558		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-149,320		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-94,874		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-1,044,764		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-13,609		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-174,699		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC	PHAS	Series 1 Preferred Stock	C - Conversion	I			-4,846		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-3,862		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-42,530		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-52,690		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-994	-5	40,420
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	X - Other	I		0.1200	41,414	5	41,414
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0.12		-41,414		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-104	-1	13,558
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	X - Other	I		0.1200	4,309	1	13,662
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0.12		-4,309		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-1,139	-6	149,320
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	X - Other	I		0.1200	47,458	6	150,459
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	X - Other	I	0.12		-47,458		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	S - Sale	I		5.0000	-42	-0	94,874
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	X - Other	I		0.1200	1,731	0	94,916
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Warrants to Purchase Series B Preferred Stock	X - Other	I	0.12		-1,731		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	S - Sale	I		5.0000	-458	-2	1,044,764
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	X - Other	I		0.1200	19,061	2	1,045,222
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Warrants to Purchase Series B Preferred Stock	X - Other	I	0.12		-19,061		0
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Common Stock	P - Purchase	I		5.0000	150,000	750		416,481
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund	PHAS	Common Stock	C - Conversion	I			266,481			266,481
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC	PHAS	Common Stock	C - Conversion	I			4,846			4,846
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	P - Purchase	I		5.0000	12,487	62		163,099
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	C - Conversion	I			150,612			150,612
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Common Stock	P - Purchase	I		5.0000	137,513	688		1,820,933
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP	PHAS	Common Stock	C - Conversion	I			1,683,420			1,683,420
2018-10-24	2018-10-22	4	Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP	PHAS	Common Stock	C - Conversion	I			52,690			52,690
2018-10-24	2018-10-22	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Series B Preferred Stock	C - Conversion	I			-3,505		0
2018-10-24	2018-10-22	4	Mow Jonathan P	PHAS	Series B Preferred Stock	C - Conversion	D			-310		0
2018-10-24	2018-10-22	4	Mow Jonathan P	PHAS	Series B Preferred Stock	M - Exercise	D		0.1200	310	0	310
2018-10-24	2018-10-22	4	Mow Jonathan P	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	D	0.12		-310		0
2018-10-24	2018-10-22	4	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock	C - Conversion	I			3,505			48,699
2018-10-24	2018-10-22	4	Mow Jonathan P	PHAS	Common Stock	C - Conversion	D			310			310
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Series D Preferred Stock	C - Conversion	I			-226,061		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-24,709		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-272,107		0
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-40,420		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-13,558		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-149,320		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-94,874		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-1,044,764		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-13,609		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-174,699		0
2018-10-24	2018-10-22	4	Thorp Clay By Catalysta Ventures, LLC	PHAS	Series 1 Preferred Stock	C - Conversion	I			-4,846		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-3,862		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-42,530		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Series 1 Preferred Stock	C - Conversion	I			-52,690		0
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-994	-5	40,420
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0.1200	41,414	5	41,414
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0.12		-41,414		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-104	-1	13,558
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0.1200	4,309	1	13,662
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0.12		-4,309		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-1,139	-6	149,320
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0.1200	47,458	6	150,459
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0.12		-47,458		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	S - Sale	I		5.0000	-42	-0	94,874
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0.1200	1,731	0	94,916
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0.12		-1,731		0
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	S - Sale	I		5.0000	-458	-2	1,044,764
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0.1200	19,061	2	1,045,222
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0.12		-19,061		0
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Common Stock	P - Purchase	I		5.0000	150,000	750		416,481
2018-10-24	2018-10-22	4	Thorp Clay By Venture Capital Multiplier Fund	PHAS	Common Stock	C - Conversion	I			266,481			266,481
2018-10-24	2018-10-22	4	Thorp Clay By Catalysta Ventures, LLC	PHAS	Common Stock	C - Conversion	I			4,846			4,846
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	P - Purchase	I		5.0000	12,487	62		163,099
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Affiliates III, LP	PHAS	Common Stock	C - Conversion	I			150,612			150,612
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Common Stock	P - Purchase	I		5.0000	137,513	688		1,820,933
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners III, LP	PHAS	Common Stock	C - Conversion	I			1,683,420			1,683,420
2018-10-24	2018-10-22	4	Thorp Clay By Hatteras Venture Partners I, LP	PHAS	Common Stock	C - Conversion	I			52,690			52,690
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-30,334		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-6,413		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series D Preferred Stock	C - Conversion	I			-63,688		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-22,452		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-4,746		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series C-1 Preferred Stock	C - Conversion	I			-47,140		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-165,395		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-34,968		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series B Preferred Stock	C - Conversion	I			-347,250		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-56,874		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-12,025		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series AA Preferred Stock	C - Conversion	I			-119,408		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-113	-1	22,452
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0.1200	4,690	1	22,565
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0.12		-4,690		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-24	-0	4,746
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0.1200	991	0	4,770
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0.12		-991		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series C-1 Preferred Stock	S - Sale	I		5.0000	-237	-1	47,140
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series C-1 Preferred Stock	M - Exercise	I		0.1200	9,847	1	47,377
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Warrants to Purchase Series C-1 Preferred Stock	M - Exercise	I	0.12		-9,847		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series B Preferred Stock	S - Sale	I		5.0000	-81	-0	165,395
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0.1200	3,359	0	165,476
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0.12		-3,359		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series B Preferred Stock	S - Sale	I		5.0000	-18	-0	34,968
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0.1200	710	0	34,986
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0.12		-710		0
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series B Preferred Stock	S - Sale	I		5.0000	-170	-1	347,250
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Series B Preferred Stock	M - Exercise	I		0.1200	7,053	1	347,420
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Warrants to Purchase Series B Preferred Stock	M - Exercise	I	0.12		-7,053		0
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Common Stock	P - Purchase	I		5.0000	6,041	30		281,096
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II-B, LP	PHAS	Common Stock	C - Conversion	I			275,055			275,055
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Common Stock	P - Purchase	I		5.0000	1,277	6		59,429
2018-10-24	2018-10-22	4	TUFTS LINDA By FSV II, LP	PHAS	Common Stock	C - Conversion	I			58,152			58,152
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Common Stock	P - Purchase	I		5.0000	12,682	63		590,168
2018-10-24	2018-10-22	4	TUFTS LINDA By Fletcher Spaght Ventures II, LP	PHAS	Common Stock	C - Conversion	I			577,486			577,486
2018-10-17	2018-10-17	4	Mow Jonathan P	PHAS	Employee Stock Option (right to buy)	A - Award	D	5.00		220,000		220,000
2018-10-17		3	Thorp Clay	PHAS	Common Stock		D						23,598
2018-10-17		3	Thorp Clay	PHAS	Common Stock		D						23,598
2018-10-17		3	Thorp Clay	PHAS	Common Stock		D						23,598
2018-10-17		3	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock		I						90,388
2018-10-17		3	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock		I						90,388
2018-10-17		3	Mow Jonathan P By the Mow Trust dated April 17, 2008	PHAS	Common Stock		I						90,388

Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo

Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo

Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)

Conversão de derivativo

Venda ou transferência de ativos de volta para a empresa

Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa

Doação de ativos pelo ou para o insider

Swaps de capital e transações de hedge similares

Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)

Uma transação voluntariamente reportada no Formulário 4

Outro (acompanhado de uma nota explicativa descrevendo a transação)

PHASQ / PhaseBio Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5